studiedDrug

URI: https://gptkb.org/prop/studiedDrug
47 triples
GPTKB property
Alternative names (1)
testedDrug
Random triples
Subject Object
gptkb:Solidarity_trial gptkb:interferon_beta-1a
gptkb:RE-LY_trial gptkb:warfarin
gptkb:Canakinumab_Anti-inflammatory_Thrombosis_Outcomes_Study gptkb:canakinumab
gptkb:SURPASS-2 gptkb:tirzepatide
gptkb:Adaptive_COVID-19_Treatment_Trial_1 gptkb:remdesivir
gptkb:Rivaroxaban_Once_Daily_Oral_Direct_Factor_Xa_Inhibition_Compared_with_Vitamin_K_Antagonism_for_Prevention_of_Stroke_and_Embolism_Trial_in_Atrial_Fibrillation gptkb:rivaroxaban
gptkb:Justification_for_the_Use_of_Statins_in_Prevention:_an_Intervention_Trial_Evaluating_Rosuvastatin gptkb:rosuvastatin
gptkb:DESCARTES_trial gptkb:evolocumab
gptkb:ACTT-1 gptkb:remdesivir
gptkb:IMpower150 gptkb:atezolizumab
gptkb:CALM_trial gptkb:adalimumab
gptkb:ACTT-1 placebo
gptkb:COVID-19_Solidarity_Trial_(WHO) gptkb:lopinavir/ritonavir
gptkb:TRANSCEND_trial gptkb:telmisartan
gptkb:ECHO-301/KEYNOTE-252_trial gptkb:pembrolizumab
gptkb:IMpower150 gptkb:bevacizumab
gptkb:IMpower150 paclitaxel
gptkb:VISION_trial 177Lu-PSMA-617
gptkb:Solidarity_trial gptkb:lopinavir/ritonavir
gptkb:ROCKET_trial gptkb:rivaroxaban